Back

Laboratory aspirin resistance reversibility in coronary artery disease and chronic obstructive pulmonary disease patients after coronary stent implantation

21 May 2016 (08:30 - 17:30)
Organised by:
Congress Presentation Part of: Poster Session 1 - Drug therapy, other Drug therapy, other HFA Premium Access HEART FAILURE 2016

About the speaker

Photo
Professor Igor Pershukov

Osh State University, Osh (Kyrgyzstan)

8 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor A. Godinho (Braganca, PT)
Abstract
Presentation thumbnail
Professor G. Rosano (London, GB)
Presentation thumbnail
Professor G. KUKHARCHIK (Kotka, FI)
Abstract
Presentation thumbnail
Doctor C. Di Nora (Udine, IT)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 1 - Drug therapy, other

The Event

Event poster

HEART FAILURE 2016

21 May 2016 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Residual platelet activity and systemic inflammation in patients with chronic coronary syndrome in the context of aspirin monotherapy.
29 June 2021
thumbnail
Congress Presentation
Epidemiology and clinical impact of chronic obstructive pulmonary disease in patients with atrial fibrillation: findings from an european prospective observational registry
28 August 2023
thumbnail
Congress Presentation
Breathing patterns and ventilator efficiency in patients with acute coronary syndrome receiving ticagrelor - an analysis of the Bern Rehab Registry
30 August 2025
thumbnail
Webinar
Aspirin treatment for mitigating thrombotic risk across the cardiovascular risk continuum
6 July 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources